Pharmacy costs associated with nonformulary drug requests

American Journal of Health-System Pharmacy

Volumn 58, Issue 18, 2001, Pages 1746-1752

  Sweet, B V ^a   Stevenson, J G ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Administration; Costs; Economics; Formularies; Pharmacists, hospital; Pharmacy, institutional, hospital

Indexed keywords

CEFTRIAXONE; CITALOPRAM; DONEPEZIL; GLIMEPIRIDE; LATANOPROST; LISINOPRIL; ONDANSETRON; OXYCODONE; RIFAMPICIN; TERAZOSIN; TOLTERODINE; TRAMADOL; ZOLPIDEM;

ARTICLE; COMPUTER SYSTEM; COST BENEFIT ANALYSIS; DRUG COST; DRUG FORMULARY; DRUG INDUSTRY; DRUG USE; ELIXIR; FINANCIAL MANAGEMENT; HOSPITAL PATIENT; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0035884705     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.18.1746     Document Type: Article

References (4)

1. Where is the evidence for formulary effectiveness?
2. Intended and unintended consequences of HMO cost-containment strategies: Results from the managed care outcomes project
3. The evaluation of nonformulary prescribing in a community teaching hospital
4. Impact of a pharmacist's education program on non-formulary drug use